ASTRAZENECA PLC (AZN)
Clinical trial NCT05607719 updates: 1. completion date: 2026-06-30 → 2026-07-31 2. primary completion date: 2026-06-30 → 2026-07-31
Clinical trial NCT05607719 updates: 1. completion date: 2026-06-30 → 2026-07-31 2. primary completion date: 2026-06-30 → 2026-07-31
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical